Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C treatments in India.
Read more about ‘Killead’s Patent Application Killed by the Indian Patent Office!Category: Patents
Roche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects of Indian pharmaceutical patent law and its impact on international drug companies.
Read more about Roche’s backbone rendered brittle by Indian Patent OfficeWeekly IP Warm-UP!
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and court decisions with clarity and factual accuracy.
Read more about Weekly IP Warm-UP!Drug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology’s Humira patent after Glenmark’s pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges to Humira patents both in India and globally.
Read more about Drug Humira turns Rheumatic for Abbott BiotechnologyRPX acquires patents owned by Apple’s Rockstar Consortium for US$ 900M
RPX Corp. is acquiring around 4,000 patents from Apple’s Rockstar Consortium for US$ 900 million, effectively ending several major patent lawsuits. This deal highlights a move from litigation to licensing in managing high-value technology patents.
Read more about RPX acquires patents owned by Apple’s Rockstar Consortium for US$ 900MAstrazeneca to retain Sweetness of Onglyza
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement of Saxagliptin hydrochloride patents before their expiry.
Read more about Astrazeneca to retain Sweetness of OnglyzaPatent licensing agreement for Google and Verizon
Google and Verizon have entered a five-year patent licensing agreement to prevent litigation over patent infringements. The deal aims to reduce exposure to patent trolls and support innovation across various technologies.
Read more about Patent licensing agreement for Google and VerizonIntro to Patent Law and Patentability Requirements – Presentations by Dr. Kalyan Kankanala at NLSIU
Dr. Kalyan Kankanala’s NLSIU presentations provide a structured overview of patent law in India and the core patentability requirements. The content includes case law analysis and practical examples, reflecting updated legal developments.
Read more about Intro to Patent Law and Patentability Requirements – Presentations by Dr. Kalyan Kankanala at NLSIUFeatherbed Frame: The Frame That is Revolutionizing Motorcycle Construction
The featherbed frame, designed for Norton in 1949, marked a major advancement in motorcycle chassis technology. With superior stiffness and handling, it became a benchmark for motorcycle construction and remains influential today.
Read more about Featherbed Frame: The Frame That is Revolutionizing Motorcycle ConstructionElucidating the Patent Process – Part 1
This post describes the different types of patent applications available under Indian law and their essential procedural requirements. It provides clarity on the patent process in India, focusing on application types, filing priorities, and statutory conditions.
Read more about Elucidating the Patent Process – Part 1